Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:clozapine
|
| gptkbp:approvalYear |
2015
|
| gptkbp:brand |
gptkb:clozapine
|
| gptkbp:controlledSubstanceSchedule |
no
|
| gptkbp:FDAApproved |
yes
|
| gptkbp:form |
oral suspension
|
| gptkbp:hasBoxedWarning |
gptkb:orthostatic_hypotension
seizures myocarditis cardiomyopathy agranulocytosis increased mortality in elderly patients with dementia-related psychosis |
| https://www.w3.org/2000/01/rdf-schema#label |
Versacloz
|
| gptkbp:indication |
treatment-resistant schizophrenia
reducing risk of recurrent suicidal behavior in schizophrenia or schizoaffective disorder |
| gptkbp:manufacturer |
gptkb:Jazz_Pharmaceuticals
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:riskEvaluationMitigationStrategy |
required
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:usedFor |
schizophrenia
|
| gptkbp:bfsParent |
gptkb:clozapine
|
| gptkbp:bfsLayer |
6
|